NCT05197582 is a NA clinical trial of tele-monitoring in COVID-19 Pandemic, sponsored by Yuksek Ihtisas University.

Who is sponsoring NCT05197582?

NCT05197582 is sponsored by Yuksek Ihtisas University.

What drugs are being tested in NCT05197582?

Interventions in NCT05197582: tele-monitoring.

What condition does NCT05197582 study?

NCT05197582 studies COVID-19 Pandemic.

Is NCT05197582 still recruiting?

NCT05197582 is currently completed. Last updated 19 January 2022.

Last reviewed 2022-01-19 · How we verify

NCT05197582

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Telemonitoring on Anxiety and Quality of Life in Patients in COVID 19 Quarantine

Completed NA Last updated 19 January 2022

What this trial tests

NA trial testing tele-monitoring in COVID-19 Pandemic in 56 participants. Completed in 1 September 2021.

Timeline

1 January 2021

Primary endpoint
1 June 2021

1 September 2021

Quick facts

Lead sponsor	Yuksek Ihtisas University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	56
Start date	1 January 2021
Primary completion	1 June 2021
Estimated completion	1 September 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

tele-monitoring

Conditions studied

COVID-19 Pandemic — all drugs for COVID-19 Pandemic →

Sponsor

Yuksek Ihtisas University

Who can join

Adults 18 to 65, any sex, with COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was carried out to evaluate the effect of telemonitoring service to be given to patients kept under quarantine during the COVID 19 pandemic on anxiety and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COVID-19 Pandemic

Currently open trials in the same condition.

NCT05825651 — Long COVID and Its Associations With Health Outcomes in Older Adults · active not recruiting
NCT06927622 — Corona Virus Disease 2019 Cohort Study · recruiting
NCT05096260 — Getting to Yes, Michigan! (G2YMI) · NA · active not recruiting
NCT06208943 — Neural and Cognitive Consequences of COVID-19 Survival · recruiting

Other Yuksek Ihtisas University trials

Trials by the same sponsor.

NCT06969885 — Effect of Virtual Reality Glasses on Stress, Muscle Tension, and Physiological Parameters Before Angiography · NA · not yet recruiting
NCT07278219 — Balint Approach Group Intervention · NA · completed
NCT06542185 — Self-Efficacy Levels of Nurses on Safe Blood and Blood Product Transfusion · NA · completed
NCT06354517 — The Impact of the SENSE Program on NICU · NA · not yet recruiting
NCT05839743 — Investigation of the Effects of Aerobic Exercise, Balance Exercise and Combined Exercise Practices on Frailty, Balance, · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05197582 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yuksek Ihtisas University
Last refreshed: 19 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05197582.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing